FDA Inspection 1225730 — Nordic Pharma, Inc.
The FDA completed an inspection of Nordic Pharma, Inc. on Nov 16, 2023 in Berwyn, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berwyn, PA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)